海昌生技 Stock: price and insider trades · Taiwan

海昌生技 is a listed company. Its directors and officers file their transactions with TWSE / TPEx (MOPS). From 18 October 2025 to 18 October 2026, the disclosure feed for 海昌生技 logged 3 filings by 3 insiders.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Over the last twelve months, not one insider purchase of 海昌生技 stock was filed. Publication is fast: at least half of the trades appear on TWSE / TPEx (MOPS) on the same day. That lag is the time during which only the insider knows about the trade.

With 3 filings in twelve months, the company is more active than the median of 2 filings across the 518 companies we follow on the same exchange.

This summary is built from TWSE / TPEx (MOPS) disclosures alone and does not predict where the share price will go.